A Novel Bispecific Antibody Against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy

PLoS ONE - United States
doi 10.1371/journal.pone.0144712
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

A Novel Bispecific Single-Chain Antibody for ADAM17 and CD3 Induces T-Cell-Mediated Lysis of Prostate Cancer Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2012English

Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing

Cancers
Cancer ResearchOncology
2019English

A Novel Asymmetrical Anti-Her2/Cd3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Discovery and Structural Characterization of a Therapeutic Antibody Against Coxsackievirus A10

Science advances
Multidisciplinary
2018English

Structural Basis of a Novel Heterodimeric Fc for Bispecific Antibody Production

Oncotarget
Oncology
2017English

An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors

Science Translational Medicine
Medicine
2017English

Phase I Study of Anti-Cd3 X Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients

Prostate Cancer
Cancer ResearchOncologyUrology
2015English

A Bispecific Diabody Directed Against Prostate-Specific Membrane Antigen and CD3 Induces T-Cell Mediated Lysis of Prostate Cancer Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2007English

Evaluation of Cytotoxicity of Bispecific Antibody Against Mesothelioma

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy